Drug Profile


Latest Information Update: 26 Nov 2007

Price : $50

At a glance

  • Originator The Institute of Cancer Research
  • Class Antineoplastics
  • Mechanism of Action Alkylating agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Colorectal cancer

Most Recent Events

  • 19 Aug 1997 Phase-I clinical trials for Colorectal cancer in United Kingdom (Unknown route)
  • 04 Sep 1996 No-Development-Reported for Colorectal cancer in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top